Medicine and Dentistry
Pediatrics
83%
Airway Smooth Muscle
81%
Airway Smooth Muscle Cell
73%
Clinical Trial
48%
Asthma
43%
Cell Proliferation
32%
Extubation
32%
Airway Resistance
25%
Phosphatase
24%
Cytoskeleton
24%
Pediatrics Patient
21%
Smooth Muscle
20%
Continuous Positive Airway Pressure
20%
Actin
19%
Silo-Filler's Disease
19%
Intensive Care
19%
Y-27632
17%
Breathing
17%
Myosin
16%
Thermal Burn
16%
Methacholine
16%
Oxygen Consumption
16%
Cystic Fibrosis
16%
Clonidine
16%
Drug Therapy
16%
Isotopes of Calcium
16%
Pulmonary Hemorrhage
16%
Respiratory System
16%
Lung Mechanics
16%
Ventilator Weaning
16%
Airway Obstruction
16%
Muscle Contractility
16%
Focal Adhesion
16%
Opiate
16%
Cell Strain
16%
Morphine
14%
Health Outcomes
13%
Cell Membrane
11%
Symptom
11%
Bleeding
10%
Rho Kinase Inhibitor
9%
Smooth Muscle Contractility
9%
Barotrauma
9%
Child Health
9%
Environmental Influence
9%
Placebo
9%
Contractile Protein
8%
Botulinum Toxin
8%
Cytometry
8%
Fusion Protein
8%
Immunology and Microbiology
Airway Smooth Muscle Cell
100%
Smooth Muscle
84%
Asthma
39%
Mechanical Stress
37%
Actin
35%
Cell Proliferation
32%
Lower Respiratory Tract
32%
Rigidity
24%
Muscle Contractility
22%
Drug Megadose
21%
Arm
20%
Rural Population
16%
Lymphocyte Count
16%
Actin Filament
16%
CD4
16%
Cytoskeleton
16%
Nomenclature
16%
Focal Adhesion
16%
Steady State
16%
Tidal Volume
16%
Microfilament
16%
Pharmacokinetics
16%
Blood Transfusion
16%
T Cell
16%
Dynamics
16%
Terbutaline
16%
Asthmatic State
16%
Glucocorticoid
16%
Allele
16%
Smooth Muscle Contractility
12%
Cell Membrane
11%
Lung Function
9%
Agonist
9%
Stress Fiber
8%
Cell Culture
8%
Airway Pressure
8%
Airflow
8%
Clostridium botulinum
8%
CD3 Antigen
8%
Hyperoxia
8%
Patient Coding
8%
Body Weight
8%
Light Chain
7%
Blood Pressure
6%
Transmission Electron Microscopy
6%
Protein Content
6%
Normal Human
5%
Salbutamol
5%
High Performance Liquid Chromatography
5%
Aminophylline
5%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
77%
Actin
40%
Prospective Study
32%
Clinical Trial
32%
Terbutaline
32%
Pharmacokinetics
32%
Phosphatase
24%
Burn
22%
4 (1 Aminoethyl) N (4 Pyridyl)cyclohexanecarboxamide
18%
Cohort Study
17%
Tolerability
16%
Lung Hemorrhage
16%
Withdrawal Syndrome
16%
Clonidine
16%
Heat Shock Protein 27
16%
Phenobarbital
16%
Paxillin
16%
Lower Respiratory Tract Infection
16%
Airway Obstruction
16%
Green Fluorescent Protein
16%
Opiate
16%
Myosin
16%
Metronidazole
16%
Asthmatic State
16%
Myosin Light Chain
16%
Respiratory Tract Infection
16%
Morphine
14%
Symptom
11%
Bleeding
10%
Talin
10%
Contractile Protein
9%
Rho Kinase Inhibitor
9%
Placebo
9%
Lysophosphatidic Acid
8%
Isoprenaline
8%
RhoA Guanine Nucleotide Binding Protein
8%
Myosin Light Chain Kinase
8%
Muscle Rigidity
8%
Botulinum Toxin
8%
Fusion Protein
8%
Bronchiolitis
8%
Controlled Clinical Trial
8%
Lung Dysplasia
6%
Respiratory Failure
6%
Health Disparity
6%
Hemoglobinuria
5%
Normal Human
5%
Adult Respiratory Distress Syndrome
5%
Herbimycin A
5%
Genistein
5%
